These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3937815)

  • 21. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
    Tompson DJ; Vearer D
    Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence of two oral formulations of glyburide (glibenclamide).
    Flores-Murrieta FJ; Carrasco-Portugal Mdel C; Reyes-García G; Medina-Santillán R; Herrera JE
    Proc West Pharmacol Soc; 2007; 50():64-6. PubMed ID: 18605232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY; Moon JD; Lee YB
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
    Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
    Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of multiple oral dosing of nimodipine on glibenclamide pharmacodynamics and pharmacokinetics in elderly patients with type-2 diabetes mellitus.
    Mück W; Heine PR; Breuel HP; Niklaus H; Horkulak J; Ahr G
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):89-94. PubMed ID: 7757317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of magnesium hydroxide on the absorption and efficacy of two glibenclamide preparations.
    Neuvonen PJ; Kivistö KT
    Br J Clin Pharmacol; 1991 Aug; 32(2):215-20. PubMed ID: 1931470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uniform elimination pattern for glibenclamide in healthy Caucasian males.
    Spraul M; Streeck A; Nieradzik M; Berger M
    Arzneimittelforschung; 1989 Nov; 39(11):1449-50. PubMed ID: 2515863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a new oral antidiabetic drug HB 419 (Glibenclamide) on the plasma glucose & islet histology of two poikilotherms: Clarias batrachus & Uromastix hardwicki.
    Bhatt SD; Gill TS
    Indian J Exp Biol; 1979 Oct; 17(10):1122-6. PubMed ID: 121105
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus.
    Coppack SW; Lant AF; McIntosh CS; Rodgers AV
    Br J Clin Pharmacol; 1990 Jun; 29(6):673-84. PubMed ID: 2116159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of glibenclamide: heterogeneity in its absorption.
    Ikegami H; Shima K; Tanaka A; Tahara Y; Hirota M; Kumahara Y
    Med J Osaka Univ; 1985 Mar; 35(3-4):55-61. PubMed ID: 3934509
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hydroxylation of glibenclamide by liver biopsy specimens].
    Glogner P; Heni N
    Arzneimittelforschung; 1975 Jun; 25(6):860-1. PubMed ID: 809044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pirprofen on glibenclamide kinetics and response.
    Morrison PJ; Rogers HJ; Spector RG; Bradbrook ID; John VA
    Br J Clin Pharmacol; 1982 Jul; 14(1):123-6. PubMed ID: 6809024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dietary fiber, glucomannan, on absorption of sulfonylurea in man.
    Shima K; Tanaka A; Ikegami H; Tabata M; Sawazaki N; Kumahara Y
    Horm Metab Res; 1983 Jan; 15(1):1-3. PubMed ID: 6299917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamide.
    Chalk JB; Patterson M; Smith MT; Eadie MJ
    Eur J Clin Pharmacol; 1986; 31(2):177-82. PubMed ID: 3100314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fatal iatrogenically-induced hyperglycemia following accidental glibenclamide ingestion].
    Lemke R
    Klin Padiatr; 1990; 202(2):103-5. PubMed ID: 2109143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bio-availability of three formulations of glibenclamide.
    Meyer BH; Müller FO; Luus HG; Eckert HG
    S Afr Med J; 1989 Aug; 76(4):146-7. PubMed ID: 2503895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption of glibenclamide from different sites of the gastro-intestinal tract.
    Brockmeier D; Grigoleit HG; Leonhardt H
    Eur J Clin Pharmacol; 1985; 29(2):193-7. PubMed ID: 3935463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.